Nephrocare Health IPO
Nephrocare Health Services
Nephrocare Health IPO IPO, a Mainboard IPO was listed on the exchange on December 17, 2025. The price band is set between ₹438 –460 , with a face value of ₹2 . Retail investors can apply with a minimum of 1 lot, each comprising 32 shares — amounting to ₹14,720 at the upper price.
Nephrocare Health IPO IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Nephrocare Health IPO MAINBOARD IPO Important Dates
Get important updates regarding Nephrocare Health IPO MAINBOARD IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
IPO Timeline & Key Dates
* Tentative; subject to confirmation.
Price Band & Investment Details
| Issue Size | ₹871.04 Cr |
| Issue Price | ₹438 – ₹460 |
| Face Value | ₹2/share |
| Market Lot | 32 shares |
| Retail Min Investment | ₹14,720 |
| Listing At | NSE,BSE |
| Sale Type | both |
| Fresh Issue | ₹353.4 Cr |
| Offer for Sale | ₹517.64 Cr |
| Issue Type | book building |
Nephrocare Health IPO Grey Market Premium (GMP) - Current & Historical Rates
Last updated: 17 hours ago
Nephrocare Health IPO Grey Market Premium (GMP) History - Track Record & Historical Data
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 16 Dec 2025 Latest | ₹460 | ₹34 | ₹494 | ₹34 |
7.39%
|
12:00 PM |
| 15 Dec 2025 | ₹460 | ₹35 | ₹495 | ₹35 |
7.61%
|
12:00 PM |
| 14 Dec 2025 | ₹460 | ₹34.5 | ₹494.5 | ₹34.5 |
7.5%
|
12:00 PM |
| 13 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 12 Dec 2025 | ₹460 | ₹33 | ₹493 | ₹33 |
7.17%
|
12:00 PM |
| 11 Dec 2025 | ₹460 | ₹11.5 | ₹471.5 | ₹11.5 |
2.5%
|
12:00 PM |
| 10 Dec 2025 | ₹460 | ₹20 | ₹480 | ₹20 |
4.35%
|
12:00 PM |
Subscription (Latest Snapshot)
View Detailed SubscriptionNo snapshot available yet.
Registrar
- Registrar
- Kfin Technologies Ltd
- Registrar Phone
- 04067162222, 04079611000
- Registrar Email
- nephrocare.ipo@kfintech.com
- Registrar Address
- KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana India - 500 032.
Nephrocare Health IPO Investment Limits
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 32 | ₹14,720 |
| Retail (Max) | 13 | 416 | ₹191,360 |
| S-HNI (Min) | 14 | 448 | ₹206,080 |
| S-HNI (Max) | 67 | 2,144 | ₹986,240 |
| B-HNI (Min) | 68 | 2,176 | ₹1,000,960 |
IPO Reservation
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 9,620,900 | NA |
| Total Shares Offered | 9,620,900 | — |
Company Overview
Nephrocare Health Services, operating under the brand NephroPlus, is India’s and Asia's largest dialysis service provider. It addresses the critical and growing need for accessible and high-quality renal care through an extensive network of centers.
-
Company Growth
-
Founded by: Vikram Vuppala (along with co-founders) in 2009, based in Hyderabad.
- Model: Operates an asset-light, scale-driven model focused on outsourcing and partnerships. A significant portion of its clinics operate under revenue-sharing arrangements within private hospitals (captive clinics) or through Public-Private Partnership (PPP) contracts with government agencies.
-
Scale (As of Sep 30, 2025):
-
Clinic Network: Operates 519 clinics globally, including 51 in international markets (Philippines, Uzbekistan, Nepal).
- Market Leadership: It is the largest dialysis service provider in Asia and ranks 5th globally by treatments performed in FY25. It holds over 50% market share of the organized Indian dialysis market.
- Treatments: Performed approximately 2.9 million dialysis treatments in FY25, serving roughly 10% of India's total dialysis patient base.
-
-
- Founded In
- 2009
- Managing Director
- Vikram Vuppala
- Headquarters
- 5th Floor, D Block, iLabs Centre, Plot 18 Software Units Layout, Survey No. 64, Shaikpet, Hyderabad, Telangana, India - 500081
- Website
- nephroplus.com
- Industry
- Healthcare
You may also like
